4.6 Review

Persistent Borrelia burgdorferi Sensu Lato Infection after Antibiotic Treatment: Systematic Overview and Appraisal of the Current Evidence from Experimental Animal Models

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Neuropathogenicity of non-viable Borrelia burgdorferi ex vivo

Geetha Parthasarathy et al.

Summary: Even after treatment, some Lyme disease patients may continue to have symptoms due to unresolved bacterial remnants causing persistent neuroinflammatory processes in the central nervous system and peripheral nervous system.

SCIENTIFIC REPORTS (2022)

Review Biochemistry & Molecular Biology

Unexplained post-acute infection syndromesUnexplained post-acute infection syndromes

Jan Choutka et al.

Summary: Unexplained post-acute infection syndromes (PAISs) represent a group of chronic illnesses with overlapping clinical features with chronic fatigue syndrome (ME/CFS). This review summarizes the current knowledge of PAISs and discusses the need for basic biomedical research into the underlying mechanisms of these enigmatic chronic diseases, including the post-acute sequelae of SARS-CoV-2 infection (PASC).

NATURE MEDICINE (2022)

Letter Biochemistry & Molecular Biology

Studying severe long COVID to understand post-infectious disorders beyond COVID-19

Petter Brodin et al.

NATURE MEDICINE (2022)

Review Microbiology

Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes

Felipe C. Cabello et al.

Summary: Lyme disease is caused by tick-transmitted Borreliella burgdorferi, with an estimated annual incidence of at least 476,000 cases in the United States. 10% to 20% of patients treated with antimicrobial drugs may develop posttreatment Lyme disease syndrome (PTLDS), the etiology and pathogenesis of which remain uncertain.
Article Biochemistry & Molecular Biology

A selective antibiotic for Lyme disease

Nadja Leimer et al.

Summary: The research found that Hygromycin A can selectively eliminate B. burgdorferi, curing infections in mice, and causing less disruption to the host microbiome.
Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Editorial Material Infectious Diseases

Long COVID has exposed medicine's blind-spot

Matthew J. Burke et al.

LANCET INFECTIOUS DISEASES (2021)

Article Immunology

Genetic Background Amplifies the Effect of Immunodeficiency in Antibiotic Efficacy Against Borrelia burgdorferi

Bijaya Sharma et al.

Summary: Unrecognized immunodeficiency may contribute to antibiotics' failure in treating Lyme disease symptoms. The study showed that the efficacy of doxycycline was significantly lower in mice lacking adaptive immunity, especially B cells, with the most pronounced effect seen in immunodeficient C3H mice. Additionally, the addition of a single dose of ceftriaxone to doxycycline treatment effectively cleared infection in severely immunodeficient C3H mice.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Health Care Sciences & Services

Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study

Jeanine Ursinus et al.

Summary: In treated LB patients, the prevalence of persistent symptoms is significantly higher and the symptoms are more severe compared to individuals without LB. However, the background prevalence is also substantial, suggesting an association between LB and persistent symptoms in a relatively small subset of patients.

LANCET REGIONAL HEALTH-EUROPE (2021)

Article Immunology

Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010-2018

Kiersten J. Kugeler et al.

Summary: Using commercial insurance claims data, it was estimated that approximately 476,000 patients were diagnosed and treated for Lyme disease in the United States annually from 2010 to 2018. The results highlight the importance of accurate diagnosis and improved prevention.

EMERGING INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Venkata Raveendra Pothineni et al.

SCIENTIFIC REPORTS (2020)

Review Medicine, General & Internal

Lyme borreliosis: diagnosis and management

Bart Jan Kullberg et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Review Medicine, General & Internal

Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease

Alison W. Rebman et al.

FRONTIERS IN MEDICINE (2020)

Review Microbiology

Definitions and guidelines for research on antibiotic persistence

Nathalie Q. Balaban et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Article Multidisciplinary Sciences

Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis

Brandon L. Jutras et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Microbiology

Bacterial Persisters and Infection: Past, Present, and Progressing

Bridget Gollan et al.

ANNUAL REVIEW OF MICROBIOLOGY, VOL 73 (2019)

Article Pharmacology & Pharmacy

Plasma and Brain Concentrations of Doxycycline after Single and Repeated Doses in Wild-Type and APP23 Mice

Jacopo Lucchetti et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Article Infectious Diseases

Critical analysis of a doxycycline treatment trial of rhesus macaques infected with Borrelia burgdorferi

Gary P. Wormser et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)

Article Microbiology

Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi

Xiaoqian Wu et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Chemistry, Medicinal

In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease

Venkata Raveendra Pothineni et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2018)

Review Pharmacology & Pharmacy

Molecular mechanisms and clinical implications of bacterial persistence

Joran Elie Michiels et al.

DRUG RESISTANCE UPDATES (2016)

Review Medicine, General & Internal

Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis A Review

Edgar Sanchez et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Multidisciplinary Sciences

Normalizing the environment recapitulates adult human immune traits in laboratory mice

Lalit K. Beura et al.

NATURE (2016)

Review Microbiology

Distinguishing between resistance, tolerance and persistence to antibiotic treatment

Asher Brauner et al.

NATURE REVIEWS MICROBIOLOGY (2016)

Article Medicine, General & Internal

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease

Anneleen Berende et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Multidisciplinary Sciences

Fatigue following Acute Q-Fever: A Systematic Literature Review

Gabriella Morroy et al.

PLOS ONE (2016)

Review Multidisciplinary Sciences

Mechanisms of bacterial persistence during stress and antibiotic exposure

Alexander Harms et al.

SCIENCE (2016)

Article Medicine, General & Internal

Lyme borreliosis

Allen C. Steere et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Article Microbiology

Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells

Bijaya Sharma et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

Article Public, Environmental & Occupational Health

The burden of Lyme borreliosis expressed in disability-adjusted life years

Cees C. van den Wijngaard et al.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2015)

Article Immunology

Epidemiology of Lyme Disease

Paul S. Mead

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2015)

Article Microbiology

Morphological and biochemical features of Borrelia burgdorferi pleomorphic forms

Leena Merilainen et al.

MICROBIOLOGY-SGM (2015)

Article Multidisciplinary Sciences

Health Care Costs, Utilization and Patterns of Care following Lyme Disease

Emily R. Adrion et al.

PLOS ONE (2015)

Article Immunology

Identification of OppA2 Linear Epitopes as Serodiagnostic Markers for Lyme Disease

Giacomo Signorino et al.

CLINICAL AND VACCINE IMMUNOLOGY (2014)

Article Immunology

Xenodiagnosis to Detect Borrelia burgdorferi Infection: A First-in-Human Study

Adriana Marques et al.

CLINICAL INFECTIOUS DISEASES (2014)

Review Biochemistry & Molecular Biology

Bacterial persisters: formation, eradication, and experimental systems

Sophie Helaine et al.

TRENDS IN MICROBIOLOGY (2014)

Article Veterinary Sciences

Pharmacokinetic analysis of oral doxycycline in rhesus macaques

Monica E. Embers et al.

JOURNAL OF MEDICAL PRIMATOLOGY (2013)

Article Immunology

Treatment of Erythema Migrans With Doxycycline for 10 Days Versus 15 Days

Dasa Stupica et al.

CLINICAL INFECTIOUS DISEASES (2012)

Article Rheumatology

The amber theory of Lyme arthritis: initial description and clinical implications

Gary P. Wormser et al.

CLINICAL RHEUMATOLOGY (2012)

Article Medicine, Research & Experimental

Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy

Linda K. Bockenstedt et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Review Public, Environmental & Occupational Health

Critical Analysis of Treatment Trials of Rhesus Macaques Infected with Borrelia burgdorferi Reveals Important Flaws in Experimental Design

Gary P. Wormser et al.

VECTOR-BORNE AND ZOONOTIC DISEASES (2012)

Article Clinical Neurology

Long- Term Intrathecal Infusion of Outer Surface Protein C From Borrelia burgdorferi Causes Axonal Damage

Simone C. Tauber et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)

Article Infectious Diseases

Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi

Raphael Stricker et al.

Infection and Drug Resistance (2011)

Article Medicine, General & Internal

Subjective Symptoms after Treatment of Early Lyme Disease

Dasa Cerar et al.

AMERICAN JOURNAL OF MEDICINE (2010)

Article Microbiology

Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferi

Stephen W. Barthold et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Review Microbiology

Antibiotic Treatment of Animals Infected with Borrelia burgdorferi

Gary P. Wormser et al.

CLINICAL MICROBIOLOGY REVIEWS (2009)

Article Public, Environmental & Occupational Health

Short report:: A doxycycline hyclate rodent bait formulation for prophylaxis and treatment of tick-transmitted Borrelia burgdorferi

Marc C. Dolan et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2008)

Article Microbiology

Persistence of Borrelia burgdorferi following antibiotic treatment in mice

Emir Hodzic et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)

Article Rheumatology

Persistent Arthritis in Borrelia burgdorferi-Infected HLA-DR4-Positive CD28-Negative Mice Post-Antibiotic Treatment

Bettina Panagiota Iliopoulou et al.

ARTHRITIS AND RHEUMATISM (2008)

Article Dentistry, Oral Surgery & Medicine

Bacterial DNA persists for extended periods after cell death

Geoffrey Young et al.

JOURNAL OF ENDODONTICS (2007)

Article Immunology

Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore

Paul G. Ambrose et al.

CLINICAL INFECTIOUS DISEASES (2007)

Article Medicine, General & Internal

Early Lyme disease

Gary P. Wormser

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Infectious Diseases

Susceptibility of Borrelia afzelii strains to antimicrobial agents

E Ruzic-Sabljic et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)

Article Medicine, Research & Experimental

Cardiac involvement in non-human primates infected with the Lyme disease spirochete Borrelia burgdorferi

D Cadavid et al.

LABORATORY INVESTIGATION (2004)

Article Immunology

M-tuberculosis persistence, latency, and drug tolerance

JE Gomez et al.

TUBERCULOSIS (2004)

Article Microbiology

Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice

C Pavia et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)

Review Immunology

The rhesus model of Lyme neuroborreliosis

AR Pachner

IMMUNOLOGICAL REVIEWS (2001)

Article Medicine, General & Internal

Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.

MS Klempner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Review Medicine, General & Internal

Medical progress: Lyme disease.

AC Steere

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Microbiology

Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease

CS Pavia et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)